Susan Foller
Papers
2
Total Citations
14
H-Index
2
About
Susan Foller is a leading urologic oncologist whose research centers on optimizing surgical outcomes for complex kidney and prostate cancers. Her most impactful work is the landmark OpeRa trial, a prospective, randomized, multicenter study comparing robotic-assisted partial nephrectomy (RAPN) to open partial nephrectomy (OPN) for intermediate- and high-complexity kidney tumors. With 12 citations since its 2025 publication, this trial provides critical, high-level evidence on whether robotic surgery reduces 30-day postoperative complications, directly shaping clinical guidelines for nephron-sparing surgery. Foller’s expertise extends to the challenging population of kidney transplant recipients (KTRs), who face elevated risks of genitourinary cancers. Her multicenter study on radical prostatectomy in KTRs, though recently published with 2 citations, addresses a growing clinical need as this aging population develops prostate cancer. By systematically evaluating surgical safety and oncologic efficacy in these immunocompromised patients, Foller bridges a critical gap in transplant oncology. Her work is distinguished by its rigorous trial design and focus on patient-centered outcomes, establishing her as a key figure in advancing minimally invasive urologic surgery and improving care for vulnerable patient groups.
Research Focus
Key Achievements
Top Papers
- 1
- 2